Resultados de la búsqueda 801-810 de 3828 para anti-TNF drugs
Treatment options for men with urinary leakage Oct. 20, 2022, 01:45 p.m. CDT. septiembre 2022. Mayo Clinic researchers identify drug resistance factors for ...
This study will determine the effectiveness of the triple combination therapy, DTRM-555, in patients with R/R CLL or R/R non-Hodgkin's lymphoma. Blood and Urine ...
This trial also studies the outcomes of patients with mixed phenotype acute leukemia (MPAL), and B-lymphoblastic lymphoma (B-LLy) when treated with ALL therapy ...
Estudios clínicos · Hall WA, et al. Magnetic resonance linear accelerator technology and adaptive radiation therapy: An overview for clinicians. CA A Cancer ...
Giving reduced craniospinal radiation therapy and chemotherapy may kill tumor cells and may also reduce the late side effects of treatment. A Study to Evaluate ...
Treating Breast Cancer Patients Undergoing Trastuzumab Treatment with Carvedilol to Reduce Incidence of Heart Failure. Rochester, Minn., Scottsdale/Phoenix, ...
Depression: FDA-approved medications may help. U.S. Food and Drug Administration. https://www.fda.gov/consumers/consumer-updates/depression-fda-approved- ...
The purpose of this study is to evaluate the safety and tolerability of LYL797, a ROR1-targeted CAR T-cell therapy, in patients with ROR1+ relapsed or ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?